仁度生物：拟使用总额度不超过人民币4亿元（含本数）闲置自有资金购买理财产品

Group 1 - The company announced on January 16 that it will hold its 15th meeting of the second board of directors on January 15, 2026, to review the proposal for using idle self-owned funds to purchase financial products [1] - The total amount approved for investment in financial products is up to RMB 400 million, which includes the principal [1] - The financial products targeted for investment are low to medium risk with high safety and liquidity, including but not limited to agreed deposits, seven-day notice deposits, structured deposits, large certificates of deposit, income certificates, bond investments, money market fund investments, and entrusted financial management [1] Group 2 - The investment products will have a maturity period of no more than 12 months, and the resolution is valid for 12 months from the date of approval by the board of directors [1] - Within the approved amount and time frame, the company can use the funds in a rolling manner [1]